(Q44462687)

3 December 2017

title

Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability (English)

1 reference

3 December 2017

1 reference

1 reference

3 December 2017

Allen P Yates

0 references

Oybek Rustamov

1 reference

3 December 2017

Alexander Smith

1 reference

3 December 2017

Cheryl Fitzgerald

1 reference

3 December 2017

Monica Krishnan

1 reference

3 December 2017

Luciano G Nardo

1 reference

3 December 2017

Philip W Pemberton

1 reference

3 December 2017

language of work or name

English

0 references

publication date

9 July 2012

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

3085-3091

1 reference

Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Regulation of ovarian function: the role of anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Serum anti-Mullerian hormone throughout the human menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Anti-Mullerian hormone--is it a crystal ball for predicting ovarian ageing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

The journey from the old to the new AMH assay: how to avoid getting lost in the values

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Relationship of serum antimüllerian hormone concentration to age at menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

Diagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES260

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DES260

1 reference

release_r32sfbbl2nbrzkgif44b4jwmiy

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r32sfbbl2nbrzkgif44b4jwmiy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference